Clinical Trial Update: Interest of Propionibacterium Freudenreichii for the Treatment of Mild to Moderate Ulcerative Colitis [NA]

View source ↗

Summary

A clinical trial evaluating the probiotic Propionibacterium freudenreichii for mild to moderate ulcerative colitis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Propionibacterium freudenreichii (Propionibacterium freudenreichii)

Snippet

Sponsor: Rennes University Hospital | Conditions: Ulcerative Colitis | NA | Status: TERMINATED